Sexual history comparing cases and controls
| Variable | Cases | Controls | p value |
|---|---|---|---|
| †No penetrative vaginal or anal sexual intercourse. | |||
| ‡Injecting drug user. | |||
| *Pearson's χ2 test. | |||
| **Fisher's exact test. | |||
| Currently in sexual relationship (n=770) | 210/374 (56.1%) | 220/396 (55.6%) | 0.885** |
| Condom use for vaginal/anal sex with non-paying partner(s) in past 3 months (n=847) | |||
| None | 137/488 (28.1%) | 59/359 (16.4%) | |
| Sometimes (<50%) | 70/488 (14.3%) | 28/359 (7.8%) | |
| Usually (>50%) | 104/488 (21.3%) | 41/359 (11.4%) | <0.001* |
| Always (100%) | 138/488 (28.3%) | 209/359 (58.2%) | |
| Not applicable† | 39/488 (8.0%) | 22/359 (6.1%) | |
| Number of non-paying opposite sex partner(s) in life time (n=1461) | |||
| Nil | 96/736 (13.0%) | 95/725 (13.1%) | |
| One | 79/736 (10.7%) | 28/725 (3.9%) | <0.001* |
| Two | 69/736 (9.4%) | 39/725 (5.4%) | |
| Three or more | 492/736 (66.8%) | 563/725 (77.7%) | |
| Commercial sex worker (ever) (n=1482) | 211/741 (28.5%) | 58/741 (7.8%) | <0.001** |
| Ever had sex with: | |||
| A homo/bisexual male (n=1019) | 34/615 (5.5%) | 30/404 (7.4%) | 0.236** |
| An IDU‡ (n=1037) | 52/615 (8.5%) | 49/422 (11.6%) | 0.109** |
| A heterosexual male with multiple other partners (n=1086) | 199/638 (31.2%) | 137/448 (30.6%) | 0.842** |
| A male from outside Australia (n=1450) | 262/735 (35.6%) | 117/715 (16.4%) | <0.001** |
| Patient reported history of (n=1482) | |||
| Gonorrhoea | 84/741 (11.3%) | 54/741 (7.3%) | 0.009 |
| Syphilis | 16/741 (2.2%) | 7/741 (0.9%) | 0.910 |
| Chlamydia | 129/741 (17.4%) | 121/741 (16.3%) | 0.627 |
| PID | 97/741 (13.1%) | 27/741 (3.6%) | <0.001 |
| Genital herpes | 94/741 (12.7%) | 175/741 (23.6%) | <0.001 |
| Genital warts | 44/741 (5.9%) | 73/741 (9.9%) | 0.007 |
| Bacterial vaginosis | 176/741 (23.8%) | 226/741 (30.5%) | 0.004 |
| Candidiasis | 15/741 (2.0%) | 29/741 (3.9%) | 0.045 |
| Trichomoniasis | 81/741 (10.9%) | 55/741 (7.4%) | 0.024 |
| Urinary tract infection | |||